OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ablation of sphingosine kinase 2 suppresses fatty liver-associated hepatocellular carcinoma via downregulation of ceramide transfer protein
Xin Tracy Liu, Long Hoa Chung, Da Liu, et al.
Oncogenesis (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 17
Xin Tracy Liu, Long Hoa Chung, Da Liu, et al.
Oncogenesis (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 17
Showing 17 citing articles:
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses
Beatrice Foglia, Marc Beltrà, Salvatore Sutti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7463-7463
Open Access | Times Cited: 31
Beatrice Foglia, Marc Beltrà, Salvatore Sutti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7463-7463
Open Access | Times Cited: 31
Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis
Xin Tracy Liu, Yu Huang, Da Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Xin Tracy Liu, Yu Huang, Da Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Critical Roles of the Sphingolipid Metabolic Pathway in Liver Regeneration, Hepatocellular Carcinoma Progression and Therapy
Hiroyuki Nojima, Hiroaki Shimizu, Takashi Murakami, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 850-850
Open Access | Times Cited: 8
Hiroyuki Nojima, Hiroaki Shimizu, Takashi Murakami, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 850-850
Open Access | Times Cited: 8
Sphingosine kinase 2 in cancer: A review of its expression, function, and inhibitor development
Yanqun Luo, Haiping Xue, Ying Gao, et al.
International Journal of Biological Macromolecules (2025), pp. 141392-141392
Closed Access
Yanqun Luo, Haiping Xue, Ying Gao, et al.
International Journal of Biological Macromolecules (2025), pp. 141392-141392
Closed Access
Mechanisms of Arachidonic Acid In Vitro Tumoricidal Impact
Hatem Tallima, Rashika El Ridi
Molecules (2023) Vol. 28, Iss. 4, pp. 1727-1727
Open Access | Times Cited: 10
Hatem Tallima, Rashika El Ridi
Molecules (2023) Vol. 28, Iss. 4, pp. 1727-1727
Open Access | Times Cited: 10
SIRT3 and SIRT4 double-genes remodeled the mitochondrial network to induce hepatocellular carcinoma cell line differentiation and suppress malignant phenotypes
Lijun Zhang, Zhenning Dai, Shanshan Shi, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116168-116168
Open Access | Times Cited: 2
Lijun Zhang, Zhenning Dai, Shanshan Shi, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116168-116168
Open Access | Times Cited: 2
Integrative roles of sphingosine kinase in liver pathophysiology
Kyu Min Kim, Eun Jin Shin, Ji Hye Yang, et al.
Toxicological Research (2023) Vol. 39, Iss. 4, pp. 549-564
Open Access | Times Cited: 4
Kyu Min Kim, Eun Jin Shin, Ji Hye Yang, et al.
Toxicological Research (2023) Vol. 39, Iss. 4, pp. 549-564
Open Access | Times Cited: 4
Resveratrol suppresses NSCLC cell growth, invasion and migration by mediating Wnt/β-catenin pathway via downregulating SIX4 and SPHK2
Xiaolan Wang, Caixia Liu, Jian Wang, et al.
Journal of Chemotherapy (2023) Vol. 36, Iss. 5, pp. 411-421
Closed Access | Times Cited: 4
Xiaolan Wang, Caixia Liu, Jian Wang, et al.
Journal of Chemotherapy (2023) Vol. 36, Iss. 5, pp. 411-421
Closed Access | Times Cited: 4
Sphingosine kinase 2 and p62 regulation are determinants of sexual dimorphism in hepatocellular carcinoma
Christopher D. Green, Ryan Brown, Baasanjav Uranbileg, et al.
Molecular Metabolism (2024) Vol. 86, pp. 101971-101971
Open Access | Times Cited: 1
Christopher D. Green, Ryan Brown, Baasanjav Uranbileg, et al.
Molecular Metabolism (2024) Vol. 86, pp. 101971-101971
Open Access | Times Cited: 1
Sphingosine kinase 2 (SphK2) depletion alters redox metabolism and enhances inflammation in a diet-induced MASH mouse model
Kaitlyn G. Jackson, Derrick Zhao, Lianyong Su, et al.
Hepatology Communications (2024) Vol. 8, Iss. 12
Open Access | Times Cited: 1
Kaitlyn G. Jackson, Derrick Zhao, Lianyong Su, et al.
Hepatology Communications (2024) Vol. 8, Iss. 12
Open Access | Times Cited: 1
Deep serum lipidomics identifies evaluative and predictive biomarkers for individualized glycemic responses following low-energy diet-induced weight loss: a PREVention of diabetes through lifestyle Intervention and population studies in Europe and around the World (PREVIEW) substudy
Yingxin Celia Jiang, Kaitao Lai, Roslyn Muirhead, et al.
American Journal of Clinical Nutrition (2024) Vol. 120, Iss. 4, pp. 864-878
Closed Access | Times Cited: 1
Yingxin Celia Jiang, Kaitao Lai, Roslyn Muirhead, et al.
American Journal of Clinical Nutrition (2024) Vol. 120, Iss. 4, pp. 864-878
Closed Access | Times Cited: 1
Identification of pre‐diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis: A nested case‐control study within the ATBC cohort
Dinesh Kumar Barupal, Mark Ramos, Andrea A. Florio, et al.
International Journal of Cancer (2023) Vol. 154, Iss. 3, pp. 454-464
Open Access | Times Cited: 2
Dinesh Kumar Barupal, Mark Ramos, Andrea A. Florio, et al.
International Journal of Cancer (2023) Vol. 154, Iss. 3, pp. 454-464
Open Access | Times Cited: 2
An endothelial SOX18-mevalonate pathway axis enables repurposing of statins for infantile hemangioma
Annegret Holm, Matthew S. Graus, Jill Wylie‐Sears, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Annegret Holm, Matthew S. Graus, Jill Wylie‐Sears, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
An inducible sphingosine kinase 1 in hepatic stellate cells potentiates liver fibrosis
Jin Sol Baek, Ji Hyun Lee, Ji Hye Kim, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116520-116520
Closed Access
Jin Sol Baek, Ji Hyun Lee, Ji Hye Kim, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116520-116520
Closed Access
Exploring the role of alternative lengthening of telomere-related genes in diagnostic modeling for non-alcoholic fatty liver disease
Nan Zhu, Xiaoliang Wang, Huiting Zhu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Nan Zhu, Xiaoliang Wang, Huiting Zhu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Long non-coding RNAs-Sphingolipid Metabolism Nexus: Potential Targets for Cancer Treatment
Runsheng Chen, J H Dai, Peng Chen, et al.
Pharmacological Research (2024), pp. 107539-107539
Open Access
Runsheng Chen, J H Dai, Peng Chen, et al.
Pharmacological Research (2024), pp. 107539-107539
Open Access
SKI-349, a Sphingosine Kinases 1/2 Inhibitor, Suppresses Cell Viability, Invasion, and AKT/mTOR Signaling Pathway, and Shows Synergistic Cytotoxic Effects with Sorafenib in Hepatocellular Carcinoma
Liqiao Chen, Liangliang Wang, Zongqi Han, et al.
The Tohoku Journal of Experimental Medicine (2023) Vol. 262, Iss. 3, pp. 173-180
Open Access
Liqiao Chen, Liangliang Wang, Zongqi Han, et al.
The Tohoku Journal of Experimental Medicine (2023) Vol. 262, Iss. 3, pp. 173-180
Open Access
